Beijing, China

Fuhai Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2018.


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fuhai Zhao: Innovator in Medical Technology

Introduction

Fuhai Zhao is a prominent inventor based in Beijing, China. He is known for his significant contributions to the field of medical technology, particularly in the development of innovative solutions for treating vascular conditions.

Latest Patents

Fuhai Zhao holds a patent for a "Scaffold with drug coating for treating restenosis and preparation method thereof." This invention discloses a stent with a drug coating designed to prevent and treat restenosis. The stent comprises a drug coating that covers its surface, with active ingredients including guaiane sesquiterpene compounds P1, P2, and P3. Specifically, P1 is Zedoalactone B, P2 is a stereoisomer of P1, and P3 is Zedoarondiol. Compared to existing sirolimus-eluting stents, Zhao's drug-eluting stent effectively inhibits intimal hyperplasia and inflammatory reactions in vascular walls. It also promotes endothelialization of blood vessels post-implantation, thereby preventing long-term thrombotic complications. This innovative stent offers advantages such as small dosage, low cost, and no toxic side effects.

Career Highlights

Fuhai Zhao is affiliated with the Chinese Academy of Medical Sciences, where he continues to advance research in medical devices and treatments. His work has garnered attention for its potential to improve patient outcomes in vascular health.

Collaborations

Zhao collaborates with notable colleagues, including Yuanyuan Cui and Lei Zhang, who contribute to his research endeavors and innovations in the medical field.

Conclusion

Fuhai Zhao's contributions to medical technology, particularly through his patented stent design, highlight his role as an innovator in the field. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…